Letrozole versus clomiphene citrate for superovulation in Egyptian women with unexplained infertility: a randomized controlled trial

被引：0
|
作者：
Moustafa I. Ibrahim
Rowaa A. Moustafa
Ahmed A. Abdel-Azeem
机构：
[1] Ain Shams University,Department of Obstetrics and Gynecology
来源：
Archives of Gynecology and Obstetrics | 2012年 / 286卷
关键词：
Clomiphene citrate; Letrozole; Unexplained infertility; Superovulation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1581 / 1587
页数：6
相关论文
共 50 条
  • [21] Letrozole, Gonadotropin, or Clomiphene for Unexplained Infertility
    Diamond, M. P.
    Legro, R. S.
    Coutifaris, C.
    Alvero, R.
    Robinson, R. D.
    Casson, P.
    Christman, G. M.
    Ager, J.
    Huang, H.
    Hansen, K. R.
    Baker, V.
    Usadi, R.
    Seungdamrong, A.
    Bates, G. W.
    Rosen, R. M.
    Haisenleder, D.
    Krawetz, S. A.
    Barnhart, K.
    Trussell, J. C.
    Ohl, D.
    Jin, Y.
    Santoro, N.
    Eisenberg, E.
    Zhang, H.
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (13): : 1230 - 1240
  • [22] RANDOMIZED CONTROLLED TRIAL OF COMBINED LETROZOLE AND CLOMIPHENE (CLC II) VERSUS LETROZOLE MONOTHERAPY FOR WOMEN WITH ANOVULATION
    Mejia, Rachel B.
    Summers, Karen M.
    Kresowik, Jessica
    Cooney, Laura G.
    Mancuso, Abigail C.
    Capper, Emily A.
    Bhagavath, Bala
    Van Voorhis, Bradley J.
    FERTILITY AND STERILITY, 2024, 122 (04) : E75 - E75
  • [23] Antagonist protocol versus clomiphene in unexplained infertility: A randomized controlled study
    Nada, Adel M.
    ElSetohy, Khaled A.
    Banat, Moh'd M.
    Shaheen, Ahmed F.
    TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2016, 55 (03): : 326 - 330
  • [24] A randomized controlled trial of combination letrozole and clomiphene citrate or letrozole alone for ovulation induction in women with polycystic ovary syndrome
    Mejia, Rachel B.
    Summers, Karen M.
    Kresowik, Jessica D.
    Van Voorhis, Bradley J.
    FERTILITY AND STERILITY, 2019, 111 (03) : 571 - +
  • [25] LETROZOLE ALONE OR LETROZOLE GONADOTROPIN COMBINATION AS FIRST LINE FOR SUPEROVULATION IN WOMEN WITH UNEXPLAINED INFERTILITY UNDERGOING INTRAUTERINE INSEMINATION (IUI): A PROSPECTIVE RANDOMIZED TRIAL
    Malhotra, N.
    Karmakar, D.
    Kumar, S.
    FERTILITY AND STERILITY, 2012, 98 (03) : S258 - S258
  • [26] Effect of clomiphene citrate on uterine hemodynamics in women with unexplained infertility
    Omran, Eman
    El-Sharkawy, Mohamed
    El-Mazny, Akmal
    Hammam, Mohamed
    Ramadan, Wafaa
    Latif, Dina
    Samir, Dalia
    Sobh, Sherine
    INTERNATIONAL JOURNAL OF WOMENS HEALTH, 2018, 10 : 147 - 152
  • [27] Follicle stimulating hormone versus clomiphene citrate in intrauterine insemination for unexplained subfertility: a randomized controlled trial
    Danhof, N. A.
    van Wely, M.
    Repping, S.
    Koks, C.
    Verhoeve, H. R.
    de Bruin, J. P.
    Verberg, M. F. G.
    van Hooff, M. H. A.
    Cohlen, B. J.
    van Heteren, C. F.
    Fleischer, K.
    Gianotten, J.
    van Disseldorp, J.
    Visser, J.
    Broekmans, F. J. M.
    Mol, B. W. J.
    van der Veen, F.
    Mochtar, M. H.
    HUMAN REPRODUCTION, 2018, 33 (10) : 1866 - 1874
  • [28] A randomized controlled trial of the efficacy of rosiglitazone and clomiphene citrate versus metformin and clomiphene citrate in women with clomiphene citrate-resistant polycystic ovary syndrome
    Rouzi, AA
    Ardawi, MSM
    FERTILITY AND STERILITY, 2006, 85 (02) : 428 - 435
  • [29] RETRACTION: Clomiphene citrate or aromatase inhibitors for superovulation in women with unexplained infertility undergoing intrauterine insemination: a prospective randomized trial (Retraction of Vol 92, Pg 1355, 2009)
    Badawy, Ahmed
    Elnashar, Abubaker
    Totongy, Mohamed
    FERTILITY AND STERILITY, 2020, 114 (03) : 670 - 670
  • [30] Letrozole Compared With Clomiphene Citrate for Unexplained Infertility A Systematic Review and Meta-analysis
    Eskew, Ashley M.
    Bedrick, Bronwyn S.
    Hardi, Angela
    Stoll, Carolyn R. T.
    Colditz, Graham A.
    Tuuli, Methodius G.
    Jungheim, Emily S.
    OBSTETRICS AND GYNECOLOGY, 2019, 133 (03): : 437 - 444
12345